ClinicalTrials.Veeva

Menu

Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4 (EFIL)

Rutgers The State University of New Jersey logo

Rutgers The State University of New Jersey

Status

Enrolling

Conditions

Hydrocephalus
Intraventricular Hemorrhage of Prematurity

Treatments

Device: Low Level Laser Therapy for Intraventricular Hemorrhage of Prematurity

Study type

Interventional

Funder types

Other

Identifiers

NCT06797219
Pro2023001886

Details and patient eligibility

About

The primary purpose of this study is to serve as a pilot study of the EFIL device treatment feasibility of IVH grades 3,4 to guide development of a larger trial. Primary outcomes will assess the following: safety of intervention, recruitment and consent process, acceptability of intervention by parents, retention rates, selection of most appropriate outcome measures, provide sample size estimates for a larger trial, increase the researchers' experience with the study intervention. A complete list of objectives and aims are listed under "Objectives". This study hopes to treat 12-24 neonates using 650nm light of irradiance 10mW/cm2 for 5 minutes twice a day each day for 12 days. We will also call the parents at 6 months and 12 months to track developmental milestones.

Enrollment

24 estimated patients

Sex

All

Ages

Under 1 month old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • neonates with intraventricular hemorrhage grade 3 or 4 less than 1 month old.

Exclusion criteria

  • neonates without IVH grade 3/4 or older than 1 month.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

24 participants in 1 patient group

Non-blinded, open label experimental arm
Experimental group
Description:
The experimental arm will be administered treated with the study device. It will be 10 mW/cm\^2 of 650nm laser through use of a novel laser device given for 5 minutes twice daily for 12 days.
Treatment:
Device: Low Level Laser Therapy for Intraventricular Hemorrhage of Prematurity

Trial contacts and locations

2

Loading...

Central trial contact

Garrett Gianneschi, Medical; Onajovwe Fofah, Medical

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems